Viewpoint CSO Michael K Schultz co-authors abstract on first in class imaging agent with co-investigators at Takeda, inviCRO, and others at AACR Annual Meeting.
March 21, 2014
San Diego, CA: Viewpoint CSO Michael K Schultz served as co-author for a first in class Guanylyl Cyclase C targeted peptide labeled with PET isotope gallium-68 for tumor imaging with collaborators from Takeda Pharmaceutical International Co.(Cambridge, MA); inviCRO, LLC (Boston, MA); 3D Imaging, LLC (Little Rock, AR); University of Massachusetts Medical School (Worchester, MA); University of New Mexico Health Sciences Center (Albuquerque, NM); and University of London (London, UK). The poster presentation marks the continuation of a strong interdisciplinary collaboration to advance the potential of these exciting new compounds.
American Association of Cancer Research – Annual Meeting
San Diego, CA USA
Poster Session – Wednesday, Apr 09, 2014
# 4949: In vitro and in vivo investigation of the novel, first-in-class, Guanylyl Cyclase C (GCC) targeted 68Ga labeled heat stable peptide MLN6907 ([68Ga]MLN6907) for tumor imaging.
Donna Cvet1, Robert Robertson1, Melissa Saylor1, Jennifer Terkelsen1, Ozlem Yardibi1, Maria Borland1, Nicolas Salem1, Peter Veiby1, Todd Sells1, Mary Carsillo1, Johnny Yang1, Shu-Wen Teng1, Jack Hoppin2, Kelly Orcutt2, Jacob Hesterman2, Jeffery Norenberg3, Tamara Anderson3, Michael K Schultz4, Mary Ruscowski5, Marc Berridge6, Steven Mather7, Daniel P. Bradley1.
1. Takeda Pharmaceutical International Co., Cambridge, MA
2. InviCRO, Boston, MA
3. University of New Mexico Health Sciences Center, Albuquerque, NM
4. Radiology and Radiation Oncology, Iowa City, IA
5. Radiology, University of Massachusetts Medical School, Worcester, MA
6. 3D Imaging, Little Rock, AR
7. University of London, London, United Kingdom
Cvet D, Robertson R, Saylor M, Terkelsen J, Yardibi O, Borland M, Salem N, Veiby P, Sells T, Carsillo M, Yang J, Teng S-W, Hoppin J, Orcutt K, Hesterman J, Norenberg J, Anderson T, Schultz MK, Ruscowski M, Berridge M, Mather S, Bradley DP. (2014). In vitro and in vivo investigation of the novel, first-in-class, Guanylyl Cyclase C (GCC) targeted 68Ga labeled heat stable peptide MLN6907 ([68Ga]MLN6907) for tumor imaging. American Association for Cancer Research. Annual Meeting Abstracts. Poster# 4949. San Diego, CA USA. April 5-9.
inviCRO, LLC: www.invicro.com
Takeda Pharmaceutical International Co: www.takeda.com